{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:43:19Z","timestamp":1792590199312,"version":"4.5.0"},"reference-count":28,"publisher":"MyJove Corporation","issue":"230","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68621","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:01:10Z","timestamp":1775257270000},"source":"Crossref","is-referenced-by-count":1,"title":["Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma"],"prefix":"10.3791","author":[{"given":"Gemalene M.","family":"Sunga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Cobos Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraja","family":"Dharmaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/cbt.9.1.10905","type":"journal-article","article-title":"The molecular pathogenesis of head and neck cancer","volume":"9","author":"Klein","year":"2010","unstructured":"Klein, J. D., Grandis, J. R. The molecular pathogenesis of head and neck cancer. Cancer Biol Ther. 9 (1), 1-7 (2010).","journal-title":"Cancer Biol Ther"},{"issue":"20","key":"ref2","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.3390\/cancers16203488","type":"journal-article","article-title":"Review of current and future medical treatments in head and neck squamous cell carcinoma","volume":"16","author":"Lee","year":"2024","unstructured":"Lee, A. M., Weaver, A. N., Acosta, P., Harris, L., Bowles, D. W. Review of current and future medical treatments in head and neck squamous cell carcinoma. Cancers (Basel). 16 (20), 3488 (2024).","journal-title":"Cancers (Basel)"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1002\/mco2.702","type":"journal-article","article-title":"Head and neck cancer: Pathogenesis and targeted therapy","volume":"5","author":"Liu","year":"2024","unstructured":"Liu, Y., Zhang, N., Wen, Y., Wen, J. Head and neck cancer: Pathogenesis and targeted therapy. MedComm (Beijing). 5 (9), e702 (2024).","journal-title":"MedComm (Beijing)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3389\/fimmu.2020.01721","type":"journal-article","article-title":"The evolving landscape of PD-1\/PD-L1 pathway in head and neck cancer","volume":"11","author":"Qiao","year":"2020","unstructured":"Qiao, X. et al. The evolving landscape of PD-1\/PD-L1 pathway in head and neck cancer. Front Immunol. 11, 1721 (2020).","journal-title":"Front Immunol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s40425-018-0398-7","type":"journal-article","article-title":"Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity","volume":"6","author":"Bakos","year":"2018","unstructured":"Bakos, O., Lawson, C., Rouleau, S., Tai, L.-H. Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity. J Immunother Cancer. 6 (1), 86 (2018).","journal-title":"J Immunother Cancer"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41416-023-02186-1","type":"journal-article","article-title":"Preclinical models in head and neck squamous cell carcinoma","volume":"128","author":"Chaves","year":"2023","unstructured":"Chaves, P. et al. Preclinical models in head and neck squamous cell carcinoma. Br J Cancer. 128 (10), 1819-1827 (2023).","journal-title":"Br J Cancer"},{"key":"ref7","type":"book","article-title":"International Agency for Research on Cancer. Estimated number of new cases from 2022 to 2050, both sexes, age [0-85+]","volume-title":"Globocan","year":"2022","unstructured":"World Health Organization: International Agency for Research on Cancer. Estimated number of new cases from 2022 to 2050, both sexes, age [0-85+]. Globocan. (2022)."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-0348-0837-8_5","type":"journal-article","article-title":"The role of inflammation in head and neck cancer","volume":"816","author":"Bonomi","year":"2014","unstructured":"Bonomi, M., Patsias, A., Posner, M., Sikora, A. The role of inflammation in head and neck cancer. Adv Exp Med Biol. 816, 107-127 (2014).","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ctm2.24","type":"journal-article","article-title":"Surgical trauma-induced immunosuppression in cancer: recent advances and the potential therapies","volume":"10","author":"Tang","year":"2020","unstructured":"Tang, F., Tie, Y., Tu, C., Wei, X. Surgical trauma-induced immunosuppression in cancer: recent advances and the potential therapies. Clin Transl Med. 10 (1), 199-223 (2020).","journal-title":"Clin Transl Med"},{"issue":"85","key":"ref10","first-page":"e51253","type":"journal-article","article-title":"A mouse tumor model of surgical stress to explore the mechanisms of post-operative immunosuppression and evaluate novel perioperative immunotherapies","author":"Tai","year":"2014","unstructured":"Tai, L.-H. et al. A mouse tumor model of surgical stress to explore the mechanisms of post-operative immunosuppression and evaluate novel perioperative immunotherapies. J Vis Exp. 85, e51253 (2014).","journal-title":"J Vis Exp"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hed.27722","type":"journal-article","article-title":"Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa","volume":"46","author":"Kansal","year":"2024","unstructured":"Kansal, V., Kinney, B. L. C., Schmitt, N. C. Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa. Head Neck. 46 (5), 1056-1062 (2024).","journal-title":"Head Neck"},{"issue":"146","key":"ref12","first-page":"e59195","type":"journal-article","article-title":"Intramucosal inoculation of squamous cell carcinoma cells in mice for tumor immune profiling and treatment response assessment","author":"Oweida","year":"2019","unstructured":"Oweida, A. J. et al. Intramucosal inoculation of squamous cell carcinoma cells in mice for tumor immune profiling and treatment response assessment. J Vis Exp. 146, e59195 (2019).","journal-title":"J Vis Exp"},{"issue":"4","key":"ref13","first-page":"849","type":"journal-article","article-title":"Development of an oral cancer recurrence mouse model after surgical resection","volume":"36","author":"Behren","year":"2010","unstructured":"Behren, A. et al. Development of an oral cancer recurrence mouse model after surgical resection. Int J Oncol. 36 (4), 849-855 (2010).","journal-title":"Int J Oncol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1158\/0008-5472.CAN-12-1993","type":"journal-article","article-title":"Preventing post-operative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells","volume":"73","author":"Tai","year":"2013","unstructured":"Tai, L.-H. et al. Preventing post-operative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells. Cancer Res. 73 (1), 97-107 (2013).","journal-title":"Cancer Res"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.18632\/oncotarget.27982","type":"journal-article","article-title":"A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection","volume":"12","author":"Sharon","year":"2021","unstructured":"Sharon, S. et al. A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection. Oncotarget. 12 (13), 1201-1213 (2021).","journal-title":"Oncotarget"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1002\/ijc.31240","type":"journal-article","article-title":"Mouse model of postsurgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer","volume":"142","author":"Mermod","year":"2018","unstructured":"Mermod, M. et al. Mouse model of postsurgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer. Int J Cancer. 142 (12), 2518-2528 (2018).","journal-title":"Int J Cancer"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/0194599812442037","type":"journal-article","article-title":"Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer","volume":"147","author":"Judd","year":"2012","unstructured":"Judd, N. P., Allen, C. T., Winkler, A. E., Uppaluri, R. Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer. Otolaryngol Head Neck Surg. 147 (3), 493-500 (2012).","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/eji.202170126","type":"journal-article","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)","volume":"51","author":"Cossarizza","year":"2021","unstructured":"Cossarizza, A. et al. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur J Immunol. 51 (12), 2708-3145 (2021).","journal-title":"Eur J Immunol"},{"key":"ref19","type":"book","volume-title":"Histology, staining","author":"Gurina","year":"2025","unstructured":"Gurina, T. S., Simms, L. Histology, staining. StatPearls Publishing. PMID: 32491595 (2025)."},{"issue":"7 Suppl","key":"ref20","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.23654","type":"journal-article","article-title":"Head and neck cancer: An evolving treatment paradigm","volume":"113","author":"Cognetti","year":"2008","unstructured":"Cognetti, D. M., Weber, R. S., Lai, S. Y. Head and neck cancer: An evolving treatment paradigm. Cancer. 113 (7 Suppl), 1911-1932 (2008).","journal-title":"Cancer"},{"issue":"19","key":"ref21","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.3390\/cancers13194912","type":"journal-article","article-title":"An updated review on head and neck cancer treatment with radiation therapy","volume":"13","author":"Anderson","year":"2021","unstructured":"Anderson, G. et al. An updated review on head and neck cancer treatment with radiation therapy. Cancers (Basel). 13 (19), 4912 (2021).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","type":"journal-article","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 6 (1), 92 (2020).","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/1078-0432.CCR-19-2209","type":"journal-article","article-title":"Neoadjuvant PD-1 immune checkpoint blockade reverses functional immunodominance among tumor antigen-specific T cells","volume":"26","author":"Friedman","year":"2020","unstructured":"Friedman, J. et al. Neoadjuvant PD-1 immune checkpoint blockade reverses functional immunodominance among tumor antigen-specific T cells. Clin Cancer Res. 26 (3), 679-689 (2020).","journal-title":"Clin Cancer Res"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"e70199","DOI":"10.1002\/jbt.70199","type":"journal-article","article-title":"Neoadjuvant and adjuvant immunotherapy in the treatment of oral squamous cell carcinoma","volume":"39","author":"Zhou","year":"2025","unstructured":"Zhou, S. et al. Neoadjuvant and adjuvant immunotherapy in the treatment of oral squamous cell carcinoma. J Biochem Mol Toxicol. 39 (3), e70199 (2025).","journal-title":"J Biochem Mol Toxicol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"727433","DOI":"10.3389\/fonc.2021.727433","type":"journal-article","article-title":"Immunotherapy for head and neck cancer: a paradigm shift from induction chemotherapy to neoadjuvant immunotherapy","volume":"11","author":"Shibata","year":"2021","unstructured":"Shibata, H., Saito, S., Uppaluri, R. Immunotherapy for head and neck cancer: a paradigm shift from induction chemotherapy to neoadjuvant immunotherapy. Front Oncol. 11, 727433 (2021).","journal-title":"Front Oncol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1038\/s41467-022-31941-w","type":"journal-article","article-title":"Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC","volume":"13","author":"Saddawi-Konefka","year":"2022","unstructured":"Saddawi-Konefka, R. et al. Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat Commun. 13 (1), 4298 (2022).","journal-title":"Nat Commun"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","type":"journal-article","article-title":"Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors","volume":"13","author":"Darragh","year":"2022","unstructured":"Darragh, L. B. et al. Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors. Nat Commun. 13 (1), 7015 (2022).","journal-title":"Nat Commun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"738262","DOI":"10.3389\/fonc.2021.738626","type":"journal-article","article-title":"Defining the role of immunotherapy in the curative treatment of locoregionally advanced head and neck cancer: Promises, challenges, and opportunities","volume":"11","author":"Saddawi-Konefka","year":"2021","unstructured":"Saddawi-Konefka, R. et al. Defining the role of immunotherapy in the curative treatment of locoregionally advanced head and neck cancer: Promises, challenges, and opportunities. Front Oncol. 11, 738262 (2021).","journal-title":"Front Oncol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68621\/translationally-relevant-tumor-resection-model-for-murine-preclinical","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:06:15Z","timestamp":1792587975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68621\/translationally-relevant-tumor-resection-model-for-murine-preclinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":28,"journal-issue":{"issue":"230","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/68621","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}